COHANCE - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 3.0
✅ Positive
The stock demonstrates a strong volume spike of 4.38 million, suggesting significant buying interest today. Furthermore, the RSI at 44.6 indicates that the stock is currently neither overbought nor oversold, presenting a neutral momentum signal.
⚠️ Limitation
Despite the high volume, the MACD remains negative (-3.43), suggesting underlying selling pressure. The recent quarterly profit variance of -66.8% raises concerns about future earnings growth and could trigger further price corrections.
📉 Company Negative News
None found
📈 Company Positive News
None found
🏭 Industry
Cohance Lifesciences operates within the pharmaceutical sector, specifically focusing on contract research and manufacturing services (CRAMS). The industry is currently experiencing moderate growth driven by increasing R&D spending and outsourcing trends among major pharmaceutical companies.
🧾 Conclusion
A potential entry point for intraday trading could be at 420 ₹, targeting a profit-taking level at 430 ₹ with a stop-loss order set at 415 ₹. The significant volume suggests upside momentum is possible but the negative MACD and recent earnings decline necessitate careful risk management. Overall, this stock presents a moderate opportunity for an active trader due to high volume potential.